(Q36081470)

12 August 2017

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma (English)

1 reference

12 August 2017

hepatocellular carcinoma

1 reference

Tsai JF

1

1 reference

12 August 2017

Jeng JE

2

1 reference

12 August 2017

Ho MS

3

1 reference

12 August 2017

Chang WY

4

1 reference

12 August 2017

Lin ZY

5

1 reference

12 August 2017

Tsai JH

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

72

1 reference

12 August 2017

2

1 reference

12 August 2017

442-446

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.352

12 August 2017

0 references

cites work

Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Measuring the accuracy of diagnostic systems

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Hepatocellular carcinoma. A worldwide problem and the major risk factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Serum alphafetoprotein in hepatocellular carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Circulating immune complexes as "tumor marker" in hepatoma-bearing rats (Yoshida AH 130).

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Purification of acute phase anti-hepatitis A virus (HAV) IgM and development of an IgM solid-phase radioimmunoassay for the detection of HAV

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033981

Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study

23 September 2018

1 reference

12 December 2020

In vivo uptake of immune complexes by parenchymal and nonparenchymal liver cells in mice

1 reference

12 December 2020

Intrinsically stable IgG aggregates

1 reference

12 December 2020

Chronic liver disease: the detection and characterization of circulating immune complexes

1 reference

12 December 2020

Immune complexes and human neoplasia

1 reference

12 December 2020

IgE-containing circulating immune complexes in Churg-Strauss vasculitis

1 reference

12 December 2020

Urinary epidermal growth factor receptor-binding growth factors in patients with cancers of the digestive tract

1 reference

12 December 2020

Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B

1 reference

12 December 2020

Circulating immune complexes in chronic hepatitis C

1 reference

12 December 2020

AFP, CEA, CA 19-9 and TPA in hepatocellular carcinoma

1 reference

12 December 2020

Specificities of serum α-fetoprotein in HBsAg+ and HBsAg− patients in the diagnosis of hepatocellular carcinoma

1 reference

12 December 2020

Elevation of Circulating Immune Complexes and Its Relationship to Alpha-Fetoprotein Levels in Patients with Hepatitis B Surface Antigen-Positive Hepatocellular Carcinoma

1 reference

12 December 2020

Circulating immune complexes in hepatocellular carcinoma

1 reference

12 December 2020

Determination of Optimum Cutoff Levels of Plasma Des-&gamma;-Carboxy Prothrombin and Serum &alpha;-Fetoprotein for the Diagnosis of Hepatocellular Carcinoma using Receiver Operating Characteristic Curves

1 reference

12 December 2020

Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes

1 reference

12 December 2020

Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.352

1 reference

12 August 2017

1 reference

12 August 2017

1 reference